NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 21 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $28,000 | -30.0% | 95,411 | +46.3% | 0.00% | – |
| Q2 2015 | $40,000 | -2.4% | 65,210 | +9.4% | 0.00% | – |
| Q1 2015 | $41,000 | +7.9% | 59,623 | -0.2% | 0.00% | – |
| Q4 2014 | $38,000 | -26.9% | 59,723 | -3.7% | 0.00% | – |
| Q3 2014 | $52,000 | +10.6% | 62,023 | +4.2% | 0.00% | – |
| Q2 2014 | $47,000 | +23.7% | 59,523 | +81.9% | 0.00% | – |
| Q1 2014 | $38,000 | – | 32,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 138,000 | $170,000 | 0.16% |
| BUCKINGHAM STRATEGIC WEALTH, LLC | 56,583 | $70,000 | 0.03% |
| EXENCIAL WEALTH ADVISORS, LLC | 59,679 | $71,000 | 0.03% |
| Orbitronix, LP | 25,100 | $31,000 | 0.02% |
| DRW Securities, LLC | 183,988 | $226,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,500 | $149,000 | 0.01% |
| EP Wealth Advisors, LLC | 13,267 | $16,000 | 0.00% |
| GLENMEDE TRUST CO NA | 300,000 | $369,000 | 0.00% |
| KCM INVESTMENT ADVISORS LLC | 23,333 | $29,000 | 0.00% |
| BOSTON FAMILY OFFICE LLC | 17,500 | $22,000 | 0.00% |